Business Relations Table - o4.fyi ()

Anmelden Gast|Guest
Beispiel: brt.php?search=wide&s=wide&p=adjective&o=wideness

Domain-Statistiken für "ir.lixte.com"

51
Business Relations
52
Eindeutige Domains
20
Gefundene Einträge
BR-Relations: 51
From Domain Role To Domain Path Aktionen
/story/516593/lixte-biotechnology-nasdaq-lixt-aligns-liora-and-light-system-with-lb-100-to-push-frontier-of-cancer-treatment/
/story/527496/lixte-biotechnology-nasdaq-lixt-aligns-liora-and-light-system-with-lb-100-to-push-frontier-of-cancer-treatment/
/story/518543/lixte-biotechnology-nasdaq-lixt-aligns-liora-and-light-system-with-lb-100-to-push-frontier-of-cancer-treatment/
/story/475693/lixte-biotechnology-nasdaq-lixt-aligns-liora-and-light-system-with-lb-100-to-push-frontier-of-cancer-treatment/
/story/514004/lixte-biotechnology-nasdaq-lixt-aligns-liora-and-light-system-with-lb-100-to-push-frontier-of-cancer-treatment/
/author/christopher/page/6/
/tag/dna-repair/
/
/why-is-ethereum-best-positioned-for-institutional-adoption-than-bitcoin/
/spartan-capital-investor-conference-2025
/news-events/press-releases/detail/47/lixte-biotechnology-holdings-announces-new-appointment-to-board-of-directors
/news-events/press-releases/detail/41/lixte-biotechnology-holdings-compound-lb-205-reported-to-have-therapeutic-potential-for-gaucher-disease
/news-events/press-releases/detail/33/lixtes-lead-compound-lb-100-reported-to-enhance-chemotherapy-effectiveness-in-animal-models-of-liver-cancer
/news-events/press-releases/detail/33/lixtes-lead-compound-lb-100-reported-to-enhance-chemotherapy-effectiveness-in-animal-models-of-liver-cancer
/news-events/press-releases/detail/32/lixtes-lb-100-selected-as-one-of-informa-and-kantar-healths-2014-top-10-most-interesting-oncology-projects-to-watch
/news-events/press-releases/detail/28/lixte-biotechnology-holdings-inc-engages-biopharmaworks-llc-to-enhance-development-of-its-pipeline-of-novel-compounds
/news-events/press-releases/detail/26/lixte-biotechnology-holdings-inc-announces-exclusive-licensing-of-their-lead-anti-cancer-compound-lb-100-for-potential-treatment-of-hepatocellular-carcinoma-in-asia-to-taipei-medical-university
/news-events/press-releases/detail/25/lixte-completes-private-placement-of-convertible-preferred-stock
/news-events/press-releases/detail/24/lixte-biotechnology-holdings-inc-s-lead-compound-lb-100-reported-to-rapidly-improve-symptoms-in-a-rodent-model-of-depression
/news-events/ir-calendar/detail/20210708-2021-annual-meeting-of-stockholders